Floatz logo

FLUOROURACILUM

Actinic Keratosis (AK)

Sol-Gel Technologies, Ltd.Small moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Actinic Keratosis (AK) cohort.

Asset / SponsorPhaseRating
INGENOL MEBUTATE
University of California, San Francisco
Phase 4BB
Efudex
Sol-Gel Technologies, Ltd.
Phase 3BB
Liposomal T4N5 Lotion
National Cancer Institute (NCI)
Phase 2B
Levulan® Kerastick®
Medical Dermatology Specialists
Phase 1/2CCC
5-ala
Brigham and Women's Hospital
Phase 2CCC
5-ala
Brigham and Women's Hospital
N/AD

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →